Drug Design Presentation
Drug Design Presentation
• It aims to predict the binding mode of a compound for a given receptor as well as
the quality of the interaction and strength of noncovalent bond.
1
Disease
• Schizophrenia, a chronic brain disorder in which people interpret reality
abnormally.
• May result in some combination of hallucinations, delusions, and extremely
disordered thinking and behavior that impairs daily functioning, and can be
disabling.
Protein
7DFP: It is the structure of the dopamine D 2 receptor in complex with the
antipsychotic drug spiperone
2
METHODOLOGY:
a) PHARMACOPHORE MODELLING
• Identify a disease and select an appropriate target protein from RCSB-PDB
• Search for the Target protein in the Pharmacophore modelling software
‘Pharmit’
• Refine the search as required
• Select a database to start the search for molecules and conformers
• Further analyze and prioritize the results
• Click ‘Save’ to download the list of candidate molecules
• The list of molecules can be viewed in Biovia Discovery Studio.
3
b) MOLECULAR DOCKING
➢Search the required protein from protein databank and download
➢Swiss PDB Viewer: Purify the protein is prepared
➢PyRx software: Import the ligand; minimize and convert to pdbqt format
Load the purified protein and convert it to macromolecule
Adjust the grid size
Select all ligands & purified protein; Click forward in vina wizard
On completion save the score in .csv format; scores are obtained
➢PyMol Software: Import the potent ligand & purified protein
Save as drug-complex.pdb format
➢Biovia Discovery Studio: Open the drug-complex.pdb
The 2-D protein ligand interaction is obtained
4
RESULTS AND DISCUSSION
In Pharmit, protein is elucidated by:
• The conformational space of the flexible molecules were coeverd extensively
• Molecules were aligned by common pharmacophore features
Molecular Docking
• The ligand with the highest negative Gibb’s free energy and RMSD value 0 was
selected
• The ligand-protein complex gives information of the amino acids responsible for
interactions
• Also other interactions like Van der Waal’s Force, hydrogen bond, Pi-sigma &Pi-Pi
interactions were obtained
5
RESULTS AND DISCUSSION
Pharmacophore Modelling:
6
Molecular Docking:
CONCLUSION
The potent ligand chosen based on the optimum score, helps to estimate how
well the ligand fits and interacts with the protein's binding pocket.
9
References
• Muhammed, M. Yalcin, E. (2021) Pharmacophore Modelling in Drug
Discovery:Methodology and Current Status. Journal of the Turkish Chemical
Society. <https://dergipark.org.tr/en/download/article-file/1731809>
• Raval, K. Ganatra, T. (2022) Basics, types and applications of Molecular Docking: A
Review. IP International Journal of Comprehensive and Advanced Pharmacology
<https://www.ijcap.in/html-article/16019#idm139948998430608>
• Qing, X. Lee, X.Y. Raeymaecker, J. Tame, J. Zhang, K. Maeyer, M. Voet, A. (2014)
Pharmacophore Modelling: Advances, Limitations and Current utility in Drug
Discovery. Dovepress. <https://www.dovepress.com/pharmacophore-modeling-
advances-limitations-and-current-utility-in-dru-peer-reviewed-fulltext-article-
JRLCR>
10
THANK YOU
11